Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 191 of 1,261
  1. US 11670409

    Method and apparatus for providing a pharmacokinetic drug dosing regiment

    Takeda Pharmaceutical Company Limited · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  2. US 11667701

    Anti-PfRH5 antibodies and antigen-binding fragments thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  3. US 11667692

    T cell receptors recognizing HLA-CW8 restricted mutated KRAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  4. US 11667718

    Cancer treatment

    VANDA PHARMACEUTICALS INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  5. US 11667702

    Stable aqueous formulations of aflibercept

    Coherus BioSciences, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  6. US 11667890

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Iovance Biotherapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  7. US 11666612

    Network-based microbial compositions and methods

    Seres Therapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  8. US 11666660

    Glycan-dependent immunotherapeutic molecules

    The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  9. US 11667612

    Compositions and methods for delivering pharmaceutical agents

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  10. US 11666547

    Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)

    Northwestern University · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  11. US 11666528

    Drug implants containing enzalutamide and methods of use thereof

    The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  12. US 11666645

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  13. US 11667687

    Masked activatable interferon constructs

    CytomX Therapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  14. US 11667683

    Articles comprising a silk polypeptide for antigen delivery

    Ludwig-Maximilians-Universitat Munchen · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  15. US 11667643

    RIP1K inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  16. US 11667637

    Fused imidazo-piperidine JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  17. US 11666637

    Insulin-loaded metal-organic frameworks

    Northwestern University · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  18. US 11666661

    Methods and compounds for targeted autophagy

    The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  19. US 11667900

    Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication

    The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  20. US 11666594

    Antibody-drug conjugates comprising a cyclic dinucleotide

    Takeda Pharmaceutical Company Limited · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  21. US 11666606

    Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  22. US 11666609

    Methods of treating dog urinary tract infections

    The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  23. US 11666575

    Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  24. US 11666634

    Methods and compositions for management of gastrointestinal disorders

    The Board of Regents of the University of Texas System · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.